Financials Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse 04:00:02 2024-06-14 pm EDT 5-day change 1st Jan Change
358.9 USD +0.23% Intraday chart for Humana Inc. +2.03% -21.60%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 48,537 54,296 59,622 64,843 56,361 43,251 - -
Enterprise Value (EV) 1 50,149 56,283 68,722 70,908 63,323 48,566 48,186 47,827
P/E ratio 18.2 x 16.2 x 20.5 x 23.2 x 22.9 x 23.8 x 18.2 x 14.5 x
Yield 0.6% 0.61% 0.59% 0.62% - 1.04% 1.12% 1.19%
Capitalization / Revenue 0.75 x 0.7 x 0.72 x 0.7 x 0.53 x 0.38 x 0.37 x 0.36 x
EV / Revenue 0.77 x 0.73 x 0.83 x 0.76 x 0.6 x 0.43 x 0.42 x 0.39 x
EV / EBITDA 13.6 x 13.3 x 21.5 x 13.8 x 11.1 x 12.3 x 10.4 x 9.09 x
EV / FCF 11 x 12 x 72.6 x 20.5 x 21.3 x 24.7 x 16 x 13.5 x
FCF Yield 9.07% 8.31% 1.38% 4.89% 4.7% 4.04% 6.24% 7.42%
Price to Book 4.02 x 3.85 x 3.73 x 4.18 x 3.44 x 2.74 x 2.53 x 2.31 x
Nbr of stocks (in thousands) 132,426 132,341 128,534 126,600 123,111 120,501 - -
Reference price 2 366.5 410.3 463.9 512.2 457.8 358.9 358.9 358.9
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 64,888 77,155 83,064 92,870 106,374 114,032 115,510 121,605
EBITDA 1 3,697 4,240 3,201 5,122 5,711 3,942 4,612 5,262
EBIT 1 3,262 3,751 2,488 4,413 4,999 3,170 3,798 4,487
Operating Margin 5.03% 4.86% 3% 4.75% 4.7% 2.78% 3.29% 3.69%
Earnings before Tax (EBT) 1 3,456 4,600 3,354 3,568 3,383 2,380 3,120 3,732
Net income 1 2,707 3,367 2,933 2,806 2,489 1,799 2,329 2,823
Net margin 4.17% 4.36% 3.53% 3.02% 2.34% 1.58% 2.02% 2.32%
EPS 2 20.10 25.31 22.67 22.08 20.00 15.10 19.73 24.71
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,964 3,006 3,548
FCF margin 7.01% 6.06% 1.14% 3.73% 2.8% 1.72% 2.6% 2.92%
FCF Conversion (EBITDA) 123.02% 110.26% 29.55% 67.69% 52.13% 49.83% 65.18% 67.43%
FCF Conversion (Net income) 168.01% 138.85% 32.25% 123.56% 119.61% 109.16% 129.08% 125.69%
Dividend per Share 2 2.200 2.500 2.725 3.150 - 3.745 4.006 4.263
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 21,054 23,970 23,662 22,799 22,439 26,742 26,747 26,423 26,462 29,611 28,441 28,004 28,026 30,171 29,033
EBITDA 1 434 1,604 1,501 1,200 640 1,875 1,854 1,459 508 1,639 1,247 979.5 246.5 1,458 1,398
EBIT 1 240 1,415 1,313 1,018 458 1,657 1,530 1,258 322 1,397 1,071 790 48.88 1,308 1,214
Operating Margin 1.14% 5.9% 5.55% 4.47% 2.04% 6.2% 5.72% 4.76% 1.22% 4.72% 3.77% 2.82% 0.17% 4.33% 4.18%
Earnings before Tax (EBT) 1 -60 1,220 1,122 1,297 -71 1,614 1,262 1,098 -591 1,014 864.8 679.8 -152.7 1,245 1,123
Net income 1 -14 930 696 1,195 -15 1,239 959 832 -541 741 688.7 475.9 -137.5 896.3 796.2
Net margin -0.07% 3.88% 2.94% 5.24% -0.07% 4.63% 3.59% 3.15% -2.04% 2.5% 2.42% 1.7% -0.49% 2.97% 2.74%
EPS 2 -0.1100 7.290 5.480 9.390 -0.1200 9.870 7.660 6.710 -4.420 6.110 5.703 3.962 -1.125 7.474 6.653
Dividend per Share 2 0.7000 0.7875 0.7875 0.7875 0.7875 0.8850 0.8850 - - 0.8850 0.9800 0.9800 0.9800 1.007 1.023
Announcement Date 2/2/22 4/27/22 7/27/22 11/2/22 2/1/23 4/26/23 8/2/23 11/1/23 1/25/24 4/24/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,612 1,987 9,100 6,065 6,962 5,314 4,935 4,576
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.436 x 0.4686 x 2.843 x 1.184 x 1.219 x 1.348 x 1.07 x 0.8695 x
Free Cash Flow 1 4,548 4,675 946 3,467 2,977 1,964 3,006 3,548
ROE (net income / shareholders' equity) 21.7% 19.4% 17.9% 20.4% 20.6% 12.3% 14.6% 17%
ROA (Net income/ Total Assets) 8.84% 12.8% 7.39% 6.42% 7.21% 3.89% 4.7% 5.41%
Assets 1 30,633 26,224 39,664 43,706 34,544 46,257 49,508 52,187
Book Value Per Share 2 91.10 107.0 124.0 123.0 133.0 131.0 142.0 156.0
Cash Flow per Share 2 39.20 42.40 17.50 36.10 32.00 21.70 32.00 41.00
Capex 1 736 964 1,316 1,120 1,004 801 883 962
Capex / Sales 1.13% 1.25% 1.58% 1.21% 0.94% 0.7% 0.76% 0.79%
Announcement Date 2/5/20 2/3/21 2/2/22 2/1/23 1/25/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
358.9 USD
Average target price
371.9 USD
Spread / Average Target
+3.60%
Consensus
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. Financials Humana Inc.